As of January 9 at 3:00:00 PM EST. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 59.02k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.29 per share. | Indirect | 1,401,571 | Nov 10, 2023 |
| THEUER CHARLES P. Chief Executive Officer | Stock Award(Grant) at price 0.13 - 0.14 per share. | Direct | 948 | Oct 20, 2023 |
| THEUER CHARLES P. Chief Executive Officer | Purchase at price 0.66 - 0.75 per share. | Direct | 37,889 | Apr 27, 2023 |
| BROWN SCOTT B. Chief Financial Officer | Stock Award(Grant) at price 0.14 per share. | Direct | 482 | Apr 20, 2023 |
| OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.38 per share. | Indirect | 240,821 | Mar 9, 2023 |
| THEUER CHARLES P. Chief Executive Officer | Purchase at price 1.52 per share. | Direct | 7,600 | Mar 1, 2023 |
| THEUER CHARLES P. Chief Executive Officer | Purchase at price 1.62 per share. | Direct | 11,016 | Jan 18, 2023 |
| BROWN SCOTT B. Chief Financial Officer | Purchase at price 1.49 per share. | Direct | 5,215 | Dec 29, 2022 |
| LARUE WILLIAM R Director | Sale at price 1.26 per share. | Direct | 151 | Dec 21, 2022 |
| THEUER CHARLES P. Chief Executive Officer | Purchase at price 1.29 per share. | Direct | 29,755 | Dec 14, 2022 |
| OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.24 - 1.26 per share. | Indirect | 209,876 | Dec 14, 2022 |
| OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 0.01 per share. | Indirect | 2,215 | Dec 6, 2022 |
| OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.44 per share. | Indirect | 2,216 | Dec 6, 2022 |
Related Tickers
CDTX Cidara Therapeutics, Inc.
22.83
-8.24%
ONCT Oncternal Therapeutics, Inc.
0.5266
-24.12%
KTTA Pasithea Therapeutics Corp.
2.5800
-9.79%
NBIO Nascent Biotech, Inc.
0.0420
-30.00%
TFFP TFF Pharmaceuticals, Inc.
0.0650
-60.05%
ATXI Avenue Therapeutics, Inc.
1.8370
-2.80%
TRVN Trevena, Inc.
1.7200
+13.58%
TBPH Theravance Biopharma, Inc.
8.74
-3.43%
HALB Halberd Corporation
0.0035
-5.41%
IPIX Innovation Pharmaceuticals Inc.
0.0001
0.00%